# FDA 483 - Carlsbad Technology, Inc - November 05, 2021

Source: https://www.globalkeysolutions.net/records/483/carlsbad-technology-inc/85920274-c2fe-4caf-8721-ab5feb124835

> FDA 483 for Carlsbad Technology, Inc on November 05, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Carlsbad Technology, Inc
- Inspection Date: 2021-11-05
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of Carlsbad Technology, Inc. in Carlsbad, CA, a manufacturer, revealed a significant deviation from written production and process control procedures. Specifically, the firm failed to follow its own procedures, resulting in the inadvertent blending of different batches of Famotidine 20 mg, yet decided to release the affected product.

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/saied-a-asbagh/215bfa90-995f-4310-baf3-cd9d37639b7b)

Company: https://www.globalkeysolutions.net/companies/carlsbad-technology-inc/f287d8a3-2125-436c-83a1-500be9641608

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6